# A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens

> **NCT00117273** · PHASE3 · COMPLETED · sponsor: **Duramed Research** · enrollment: 36 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Seasonale [levonorgestrel (LNG)/ethinyl estradiol (EE)]
- **DRUG:** Seasonique (LNG/EE and EE)
- **DRUG:** Portia (LNG/EE)

## Key facts

- **NCT ID:** NCT00117273
- **Lead sponsor:** Duramed Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2014-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00117273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00117273, "A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00117273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*